Lastly, genes associated with lipid transporters such as FABP7 and retinoid X receptor gamma (RXRG) were repressed, while FGF21, a biomarker candidate for NAFLD was up-regulated. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.